FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102457158> ?p ?o ?g. }

• W2102457158 endingPage "IN10" @default.
• W2102457158 startingPage "620" @default.
• W2102457158 abstract "Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is increasing at a near epidemic rate. We investigated whether the mammalian (or mechanistic) target of rapamycin (mTOR) inhibitor, rapamycin, can be used as a concurrent agent to standard-of-care cisplatin/radiation therapy (CRT) to attenuate tumor lactate production, thus enhancing CRT-induced immune-mediated clearance of this antigenic tumor type. A C57Bl/ 6-derived mouse oropharyngeal epithelial cell line retrovirally transduced with HPV type 16 E6/E7 and human squamous cell carcinoma cell lines were evaluated for their response to rapamycin in vitro with proliferation assays, Western blots, and lactate assays. Clonogenic assays and a preclinical mouse model were used to assess rapamycin as a concurrent agent to CRT. The potential of rapamycin to enhance immune response through lactate attenuation was assessed using quantitative tumor lactate bioluminescence and assessment of cell-mediated immunity using E6/E7-vaccinated mouse splenocytes. Rapamycin alone inhibited mTOR signaling of all cancer cell lines tested in vitro and in vivo. Furthermore, rapamycin administered alone significantly prolonged survival in vivo but did not result in any long-term cures. Given concurrently, CRT/rapamycin significantly enhanced direct cell killing in clonogenic assays and prolonged survival in immunocompromised mice. However, in immunocompetent mice, concurrent CRT/rapamycin increased long-term cures by 21%. Preliminary findings suggest that improved survival involves increased cell killing and enhanced immune-mediated clearance in part due to decreased lactate production. The results may provide rationale for the clinical evaluation of mTOR inhibitors concurrent with standard-of-care CRT for treatment of HPV-positive HNSCC." @default.
• W2102457158 created "2016-06-24" @default.
• W2102457158 creator A5001820251 @default.
• W2102457158 creator A5038753309 @default.
• W2102457158 creator A5038916234 @default.
• W2102457158 creator A5056934029 @default.
• W2102457158 creator A5059504870 @default.
• W2102457158 creator A5069410253 @default.
• W2102457158 date "2013-06-01" @default.
• W2102457158 modified "2023-10-06" @default.
• W2102457158 title "Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition" @default.
• W2102457158 cites W1495907134 @default.
• W2102457158 cites W1546985550 @default.
• W2102457158 cites W1560846896 @default.
• W2102457158 cites W1977270885 @default.
• W2102457158 cites W1990434160 @default.
• W2102457158 cites W1990956554 @default.
• W2102457158 cites W1993499986 @default.
• W2102457158 cites W1996445525 @default.
• W2102457158 cites W1997714593 @default.
• W2102457158 cites W2006977359 @default.
• W2102457158 cites W2007416032 @default.
• W2102457158 cites W2014409199 @default.
• W2102457158 cites W2017525816 @default.
• W2102457158 cites W2023243932 @default.
• W2102457158 cites W2026996973 @default.
• W2102457158 cites W2029255902 @default.
• W2102457158 cites W2034228225 @default.
• W2102457158 cites W2041934857 @default.
• W2102457158 cites W2051854622 @default.
• W2102457158 cites W2054185186 @default.
• W2102457158 cites W2060763328 @default.
• W2102457158 cites W2060878129 @default.
• W2102457158 cites W2069154921 @default.
• W2102457158 cites W2070860179 @default.
• W2102457158 cites W2073274327 @default.
• W2102457158 cites W2090597698 @default.
• W2102457158 cites W2091601271 @default.
• W2102457158 cites W2095745144 @default.
• W2102457158 cites W2101439755 @default.
• W2102457158 cites W2103799963 @default.
• W2102457158 cites W2104065210 @default.
• W2102457158 cites W2104801234 @default.
• W2102457158 cites W2115100370 @default.
• W2102457158 cites W2115458177 @default.
• W2102457158 cites W2117256163 @default.
• W2102457158 cites W2126860097 @default.
• W2102457158 cites W2129827034 @default.
• W2102457158 cites W2131661704 @default.
• W2102457158 cites W2137388149 @default.
• W2102457158 cites W2138216581 @default.
• W2102457158 cites W2141037581 @default.
• W2102457158 cites W2141859344 @default.
• W2102457158 cites W2151170408 @default.
• W2102457158 cites W2153043270 @default.
• W2102457158 cites W2155184914 @default.
• W2102457158 cites W2162692590 @default.
• W2102457158 cites W2164671411 @default.
• W2102457158 cites W2167117306 @default.
• W2102457158 cites W2169302147 @default.
• W2102457158 cites W2170088667 @default.
• W2102457158 cites W4243213708 @default.
• W2102457158 doi "https://doi.org/10.1593/neo.13432" @default.
• W2102457158 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3664994" @default.
• W2102457158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23730210" @default.
• W2102457158 hasPublicationYear "2013" @default.
• W2102457158 type Work @default.
• W2102457158 sameAs 2102457158 @default.
• W2102457158 citedByCount "32" @default.
• W2102457158 countsByYear W21024571582013 @default.
• W2102457158 countsByYear W21024571582014 @default.
• W2102457158 countsByYear W21024571582015 @default.
• W2102457158 countsByYear W21024571582016 @default.
• W2102457158 countsByYear W21024571582017 @default.
• W2102457158 countsByYear W21024571582018 @default.
• W2102457158 countsByYear W21024571582019 @default.
• W2102457158 countsByYear W21024571582020 @default.
• W2102457158 countsByYear W21024571582021 @default.
• W2102457158 countsByYear W21024571582023 @default.
• W2102457158 crossrefType "journal-article" @default.
• W2102457158 hasAuthorship W2102457158A5001820251 @default.
• W2102457158 hasAuthorship W2102457158A5038753309 @default.
• W2102457158 hasAuthorship W2102457158A5038916234 @default.
• W2102457158 hasAuthorship W2102457158A5056934029 @default.
• W2102457158 hasAuthorship W2102457158A5059504870 @default.
• W2102457158 hasAuthorship W2102457158A5069410253 @default.
• W2102457158 hasBestOaLocation W21024571581 @default.
• W2102457158 hasConcept C117262875 @default.
• W2102457158 hasConcept C121608353 @default.
• W2102457158 hasConcept C126322002 @default.
• W2102457158 hasConcept C150903083 @default.
• W2102457158 hasConcept C203014093 @default.
• W2102457158 hasConcept C207001950 @default.
• W2102457158 hasConcept C2776530083 @default.
• W2102457158 hasConcept C2776833033 @default.
• W2102457158 hasConcept C2777921159 @default.
• W2102457158 hasConcept C502942594 @default.
• W2102457158 hasConcept C62478195 @default.

• next